These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 238154)

  • 1. Proceedings: Effect of chronic treatment with perazine (Taxilan-R) on the pharmacokinetic behaviour of phenazone in man.
    Schüppel RV; Petruch F
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R90. PubMed ID: 238154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in drug elimination under the influence of perazine therapy (author's transl)].
    Petruch F; Schüppel R; Breyer U
    Arzneimittelforschung; 1976; 26(6):1154-5. PubMed ID: 9113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the pharmacokinetics of phenazone in man (author's transl)].
    Brinkmann HJ; Hengstmann JH; Müller F
    Arzneimittelforschung; 1977; 27(8):1609-12. PubMed ID: 578756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of metronidazole on phenazone metabolism].
    Staiger C; Wang NS; de Vries J; Weber E
    Arzneimittelforschung; 1984; 34(1):89-91. PubMed ID: 6538427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of metyrapone (Metopiron) on the half-life time of phenazone (Antipyrine) in rabbits.
    Bârzu T; Cuparencu B; Veress Mutu C
    Physiologie; 1976; 13(4):311-4. PubMed ID: 828751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
    Eichelbaum M; Ochs HR; Roberts G; Somogyi A
    Arzneimittelforschung; 1982; 32(5):575-8. PubMed ID: 7201837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
    Albanus L; Jönsson M; Sparf B
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):63-9. PubMed ID: 300543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photo-decomposition and metabolism of the phenothiazine drug perazine.
    Schley J
    Arzneimittelforschung; 1986 Apr; 36(4):635-7. PubMed ID: 2872901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of the synergistic effect of perazine and hexobarbital.
    Jend HH; Coper H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(2):219-32. PubMed ID: 4150089
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Interaction between piperazine and some phenothiazine derivatives.
    Natu MV; Shastry S; Agarwal SL
    Indian J Physiol Pharmacol; 1974; 18(3):195. PubMed ID: 4154919
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of age on antipyrine metabolism in patients with gastric cancer.
    Higuchi T; Nakamura T; Uchino H
    J Natl Cancer Inst; 1980 Nov; 65(5):897-900. PubMed ID: 6933259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the regulation of antipyrine and oxazepam metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole does not impair antipyrine clearance in humans.
    Blyden GT; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):225-6. PubMed ID: 3733272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Binding of perazine metabolites and phenothiazine derivatives to acid alpha 1-glycoprotein].
    Schley J
    Arzneimittelforschung; 1983; 33(2):185-7. PubMed ID: 6133521
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
    Sharma B; Mehta S; Nain CK; Mathur VS
    Drug Nutr Interact; 1985; 3(2):93-8. PubMed ID: 3921335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Longitudinal studies on the metabolite pattern of perazine and related phenothiazines in human and animal].
    Breyer U
    Arzneimittelforschung; 1974 Jul; 24(7):989-90. PubMed ID: 4152695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.